tiprankstipranks
Bicycle Therapeutics Ltd (BCYC)
NASDAQ:BCYC
US Market

Bicycle Therapeutics (BCYC) Income Statement

Compare
370 Followers

Bicycle Therapeutics Income Statement

Last quarter (Q3 2024), Bicycle Therapeutics's total revenue was $2.68M, a decrease of -50.00% from the same quarter last year. In Q3, Bicycle Therapeutics's net income was $-50.80M. See Bicycle Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 26.98M$ 14.46M$ 11.70M$ 10.39M$ 13.80M
Gross Profit
$ 20.51M$ 10.78M$ -33.18M$ -22.76M$ -11.74M
Operating Expenses
$ 216.92M$ 131.12M$ 77.31M$ 62.35M$ 40.10M
Depreciation and Amortization
$ 6.55M$ 3.69M$ 1.41M$ 1.29M$ 963.97K
EBITDA
$ -183.40M$ -112.96M$ -64.08M$ -50.39M$ -30.03M
Operating Income
$ -189.95M$ -116.65M$ -65.62M$ -51.96M$ -26.30M
Other Income/Expenses
$ 10.74M$ 2.41M$ -2.86M$ 226.00K$ -4.56M
Pretax Income
$ -179.21M$ -114.24M$ -68.48M$ -51.73M$ -30.86M
Net Income
$ -180.66M$ -112.72M$ -66.82M$ -51.01M$ -30.61M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -5.08$ -3.80$ -2.67$ -2.66$ -2.77
Diluted EPS
$ -5.08$ -3.80$ -2.67$ -2.66$ -2.77
Weighted Average Shares Outstanding
35.59M 29.66M 25.06M 19.15M 11.05M
Weighted Average Shares Outstanding (Diluted)
35.59M 29.66M 25.06M 19.15M 11.05M
Currency in USD

Bicycle Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis